Klor-con m10 and Diabetes - a phase IV clinical study of FDA data

Summary:

Diabetes is reported as a side effect among people who take Klor-con m10 (potassium chloride), especially for people who are male, 60+ old, also take Lasix, and have Narcolepsy.

The phase IV clinical study analyzes which people have Diabetes when taking Klor-con m10. It is created by eHealthMe based on reports of 1,290 people who have side effects when taking Klor-con m10 from the FDA, and is updated regularly.

What is Klor-con m10?

Klor-con m10 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,379 Klor-con m10 users. Check the latest studies of Klor-con m10.

What is Diabetes?

Diabetes is found to be associated with 2,011 drugs and 2,857 conditions by eHealthMe. Check the latest studies of Diabetes.

On Jul, 16, 2026

1,290 people reported to have side effects when taking Klor-con m10.
Among them, 14 people (1.09%) have Diabetes.

Among these 14 people:

What is the gender of people who have Diabetes when taking Klor-con m10? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Diabetes when taking Klor-con m10? *

What are other drugs people take besides Klor-con m10? *

What are other side effects people have besides Diabetes? *

Insomnia (sleeplessness): 6 people, 42.86%
Feeling Abnormal: 4 people, 28.57%
Sleep Apnea Syndrome: 3 people, 21.43%
Fall: 3 people, 21.43%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Abdominal Discomfort: 2 people, 14.29%
Joint Pain: 2 people, 14.29%
Diarrhea: 2 people, 14.29%
Dizziness: 2 people, 14.29%
Fatigue (feeling of tiredness): 2 people, 14.29%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 28.57%
Prostate Cancer Stage Iv: 2 people, 14.29%
Prostate Cancer: 2 people, 14.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 14.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 1 person, 7.14%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 7.14%
Bacterial Infection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con m10 and have Diabetes?

- Check whether Diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con m10:

Klor-con m10 (1,379 reports)

Diabetes treatments and more:

Diabetes (466,613 reports)

Browse all side effects of Klor-con m10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetes:

Diabetes (2,011 drugs)

Browse all the conditions that are associated with Diabetes:

Diabetes (2,857 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con m10) and Klor-con m10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.